지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한외과학회 Annals of Surgical Treatment and Research Annals of Surgical Treatment and Research Vol.108 No.1
- 발행연도
- 2025.1
- 수록면
- 12 - 19 (8page)
이용수
초록· 키워드
오류제보하기
Purpose: This study aimed to evaluate current morbidity rates following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colorectal cancer and peritoneal metastasis.
Methods: A total of 42 patients who underwent CRS and HIPEC for colorectal cancer with peritoneal metastasis at a single tertiary referral center between January 2022 and December 2022 were included. Perioperative outcomes and postoperative complications were prospectively assessed.
Results: The mean peritoneal cancer index (PCI) was 16.0. The distribution of PCI scores was as follows: <10, 33.3%; 10-19, 26.2%; and ≥ 20, 40.5%. Completeness of the cytoreduction (CCR) scores were as follows: 57.1% of patients achieved CCR-0, 16.7% achieved CCR-1, 7.1% achieved CCR-2, and 19.0% achieved CCR-3. The mean operation time was 9.1 hours, and the median hospital stay was 17.0 days. Postoperative complications occurred within 30 days in 47.6% of cases and between 30 and 60 days in 11.9% of cases. Reoperation within 30 days was required in 5 cases, and 1 patient died within 30 days. The most common complications were pleural effusion (5 patients), anastomosis site leakage (3 patients), and pneumonia (3 patients). Patients with higher PCI scores were more likely to experience complications (P = 0.038).
Conclusion: Although CRS and HIPEC are still associated with high morbidity and mortality compared to other colorectal surgeries, outcomes have improved with increased experience. These results suggest that the procedure is becoming a more acceptable treatment option over time.
Methods: A total of 42 patients who underwent CRS and HIPEC for colorectal cancer with peritoneal metastasis at a single tertiary referral center between January 2022 and December 2022 were included. Perioperative outcomes and postoperative complications were prospectively assessed.
Results: The mean peritoneal cancer index (PCI) was 16.0. The distribution of PCI scores was as follows: <10, 33.3%; 10-19, 26.2%; and ≥ 20, 40.5%. Completeness of the cytoreduction (CCR) scores were as follows: 57.1% of patients achieved CCR-0, 16.7% achieved CCR-1, 7.1% achieved CCR-2, and 19.0% achieved CCR-3. The mean operation time was 9.1 hours, and the median hospital stay was 17.0 days. Postoperative complications occurred within 30 days in 47.6% of cases and between 30 and 60 days in 11.9% of cases. Reoperation within 30 days was required in 5 cases, and 1 patient died within 30 days. The most common complications were pleural effusion (5 patients), anastomosis site leakage (3 patients), and pneumonia (3 patients). Patients with higher PCI scores were more likely to experience complications (P = 0.038).
Conclusion: Although CRS and HIPEC are still associated with high morbidity and mortality compared to other colorectal surgeries, outcomes have improved with increased experience. These results suggest that the procedure is becoming a more acceptable treatment option over time.
목차
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis
Annals of Coloproctology
2020 .01
-
Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer : 2-year follow-up results at a single institution in Korea
Annals of Surgical Treatment and Research
2016 .10
-
Single Center Experience With Hyperthermic Intraperitoneal Chemotherapy
Annals of Coloproctology
2017 .01
-
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy as Treatment Options for Peritoneal Metastasis of Advanced Gastric Cancer
Journal of Gastric Cancer
2018 .09
-
Cytoreductive Surgery and Intra-Peritoneal Chemotherapy for Peritoneal Metastasis of Colorectal Cancer: Analysis of Prognostic Factors Related to Survival
대한외과학회 학술대회 초록집
2021 .05
-
[Colorectal] Preliminary Results of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Colorectal Peritoneal Metastasis: A Single Institutional Experience
대한외과학회 학술대회 초록집
2022 .11
-
Treatment for Peritoneal Metastasis of Patients With Colorectal Cancer
Annals of Coloproctology
2021 .12
-
[Colorectal] Short-term Outcomes of Hyperthermic Intraperitoneal Chemotherapy Versus Early Postoperative Intraperitoneal Chemotherapy in Colorectal or Appendiceal Malignancies with Peritoneal Metastases: A 20-year Single-center Retrospective Study Experience
대한외과학회 학술대회 초록집
2021 .11
-
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in management of peritoneal carcinomatosis: Single center experience in Korea
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2019 .12
-
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy as Treatment Options for Peritoneal Metastasis of Advanced Gastric Cancer
대한외과학회 학술대회 초록집
2018 .11
-
Outcome of Colorectal Surgery in Elderly Populations
Annals of Coloproctology
2016 .01
-
[Colorectal] The Survival Analyses for Colorectal Cancer Patients with Mitomycin-C Induced Severe Neutropenia after Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery
대한외과학회 학술대회 초록집
2022 .11
-
Clinical impact of mitomycin-C induced neutropenia after hyperthermic intraperitoneal chemotherapy with cytoreductive surgery in colorectal cancer patients
대한외과학회 학술대회 초록집
2019 .10
-
난소암의 항암요법
대한의사협회지
2016 .01
-
CCR6 Is a Predicting Biomarker of Radiosensitivity and Potential Target of Radiosensitization in Rectal Cancer
Cancer Research and Treatment
2018 .01
-
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Obese Patients - A Systematic Review and Meta-Analysis
대한외과학회 학술대회 초록집
2021 .11
-
Outcomes of surgical and nonsurgical treatment for colorectal cancer in nonagenarian patients
대한임상종양학회 학술대회지
2021 .06
-
PREDICTIVE FACTORS OF POSTOPERATIVE MORBIDITY IN CYTOREDUCTIVE SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PERITONEAL SURFACE MALIGNANCIES: A SINGLE INSTITUTE INDIAN STUDY
대한임상종양학회 학술대회지
2021 .06
-
Cytoreductive Surgery And Intra-peritoneal Chemotherapy for Peritoneal Metastasis of Colorectal Cancer: Long-term Follow up Results
대한외과학회 학술대회 초록집
2020 .11
-
Laparoscopic surgery for colorectal cancer in patients over 80 years of age : the morbidity outcomes
Annals of Surgical Treatment and Research
2017 .06
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-151-25-02-092314978